Skip to main content
David Turgeon Associé/Partner Montréal

David Turgeon, PhD

Partner | Patent Agent | Leader, Intellectual Property Fasken
Jurisdiction Québec, 2005
Language(s) French, English
Office(s) Montréal, Québec City
Contact
Share
  • LinkedIn

Overview

David Turgeon is the leader of the Global Intellectual Property group, a lawyer and a patent agent. He represents clients before different courts, protects their inventions through patents and provides strategic advice. David represents clients operating in a variety of industries, more particularly the life sciences (namely biologics), biomedical devices and manufacturing sectors.

David practice focuses in high-stakes patent litigation involving clients’ flagship products. As lead counsel on major cases, he designs litigation strategies that are both cost-effective and results-oriented for clients.

A registered patent agent in Canada and the United States, David has extensive experience in developing global strategies and coordinating litigation in different jurisdictions. He focuses on creating synergy between the different files and implementing strategies to reduce the costs of multi-jurisdictional files.

David takes a global approach to obtaining patent protection in Canada and abroad on behalf of leading companies.

He holds a doctorate and a master’s degree in physiology-endocrinology and a bachelor’s degree in microbiology. He uses his vast scientific knowledge for the benefit of clients working in the life sciences, biomedical devices and manufacturing industries.

Achievements

Client Work

  • BRP wins major lawsuit against competitor Arctic Cat, [Case - Bombardier Recreational Products Inc.], In a lawsuit launched in December 2011, Bombardier Recreational Products accused its major competitor Arctic Cat of infringing BRP’s patents related to its revolutionary Ski-Doo REV snowmobiles. BRP is a global leader in snowmobiles, power sports vehicles and propulsion systems with over 75 years...
  • Fasken's expertise for increased food security in Quebec, [Case - Moisson Rive-Sud and Resto Plateau], Fasken is committed to help Quebecers have access to fresh, healthy and nutritious food. Organizations that provide food and meals to those in need are key players in that respect. Year after year, they are increasingly solicited. The COVID-19 pandemic has brought an even greater demand, and has ...
  • LDetek is joining Battery Ventures’ Process Sensing Technologies group, [Deal - LDetek inc.], On June 6, 2018, Battery Ventures, a global technology investment company, entered into an agreement for its process measurement platform, Process Sensing Technologies (PST), to acquire LDetek, a global manufacturer of gas chromatography instruments and online analyzers. The terms of the LDetek t...
  • Arctic Cat Inc. v. Watson, 2015 ONSC 249, 132 C.P.R. (4th) 274, [Case - Confidential Client], David Turgeon and Kimberly Potter acted for the respondent in the Superior Court of Justice – Ontario case Arctic Cat Inc. et al. v. Peter Watson (PDF).
  • Counselled Eurocopter in regards to Bell Textron, [Deal - Eurocopter], In a judgment rendered September 24, 2013, the Federal Court of Appeal of Canada upheld a previously-rendered decision finding that Bell Helicopter had intentionally infringed a patent held by Eurocopter and ordering Bell Helicopter to pay punitive damages. The trial judgment concluded that Bell ...
  • Hershkovitz v. Tyco Safety Products Canada Ltd., 2009 FC 256, 73 C.P.R. (4th) 331 (F.C.), [Case - Tyco Safety Products Canada], Hershkovitz v. Tyco Safety Products Canada Ltd., 2009 FC 256, 73 C.P.R. (4th) 331 (F.C.). On March 12, 2009, Judge Luc Martineau of the Federal Court of Canada  handed down his decision in Hershkovitz et al. v. Tyco Safety Products Canada Ltd., 2009 FC 256. The judgement is a clear victory for t...
  • Medipattern closes US$5.2 million bought-deal financing, [Deal - Research Capital], On August 2, 2007, Medipattern Corporation announced that it had closed its bought deal with Research Capital Corporation. Medipattern issued 4,730,000 common shares at a price of $1.10 per share for aggregate gross proceeds of $5,203,000. On August 17, Research Capital partially exercised an ove...

Career & Education

Education

  • Registered Patent Agent, United States
  • Registered Patent Agent, Canada
  • LLB Université Laval
  • Ph. D., Physiology-Endocrinology Université Laval
  • BSc Université Laval

Memberships & Affiliations

  • Member of the Québec City Bar
  • Member of the Québec Bar
  • Member of the Canadian Bar Association
  • Associate member of the Canadian Intellectual Property Office
  • Member of the American Bar Association

Knowledge

Events

News

Publications

Speaking Engagements

  • Is it Really So Obvious? Recent Struggles to Apply the Sanofi Test for Obviousness, 11/19/2019
  • Le litige de brevet: une stratégie de guerre? (Available in French only), 6/18/2019
  • Quelles sont les clés du succès pour une entreprise dans le secteur des sciences de la vie?, 4/24/2019
Speaker Is it Really So Obvious? Recent Struggles to Apply the Sanofi Test for Obviousness IPIC Advanced Webinar Serie location location Webinar
Speaker Le litige de brevet: une stratégie de guerre? (Available in French only) FIBEQ location location Trois-Rivières
Speaker Quelles sont les clés du succès pour une entreprise dans le secteur des sciences de la vie? Effervescence - Montréal InVivo

    Subscribe

    Receive email updates from our team

    Subscribe